Amorphous solid dispersion used for preventing and treating diseases, e.g., gastroesophageal reflux disease (GERD), peptic ulcer, gastric and duodenal ulcer, Helicobacter pylori infection, dyspepsia, Zollinger-Ellison syndrome, nausea, esophagitis, and asthma, comprises tegoprazan, and excipient
2023-08-19
专利权人AMI LIFESCI PRIVATE LTD (AMIL-Non-standard)
申请日期2023-08-19
专利号IN202321055693-A
成果简介NOVELTY - Amorphous solid dispersion comprises: tegoprazan, and excipient. USE - Amorphous solid dispersion used for preventing and treating diseases, e.g., gastroesophageal reflux disease (GERD), peptic ulcer, gastric ulcer and a duodenal ulcer, Helicobacter pylori infection, dyspepsia, Zollinger-Ellison syndrome, nausea, esophagitis, and asthma. No biological data given. ADVANTAGE - The amorphous solid dispersion is stable under a long-term and stress storage condition; excellent photostability; low hygroscopicity; and improve solubility. DETAILED DESCRIPTION - INDEPENDENT CLAIMS are included for: 1. a process for the preparation of amorphous solid dispersion, which involves: (a) providing a mixture of tegoprazan and excipient in solvent; (b) removing the solvent from the mixture; and (c) isolating amorphous solid dispersion of tegoprazan; and 2. a pharmaceutical composition, which comprises: amorphous solid dispersion of tegoprazan, and excipients.
IPC 分类号A61K-031/4184 ; A61K-009/14 ; A61K-009/16
国家印度
专业领域医药卫生
语种英语
成果类型专利
文献类型科技成果
条目标识符http://119.78.100.226:8889/handle/3KE4DYBR/20755
专题中国科学院新疆生态与地理研究所
作者单位
AMI LIFESCI PRIVATE LTD (AMIL-Non-standard)
推荐引用方式
GB/T 7714
VYAS H D,MANDE H M,MEHTA T B,et al. Amorphous solid dispersion used for preventing and treating diseases, e.g., gastroesophageal reflux disease (GERD), peptic ulcer, gastric and duodenal ulcer, Helicobacter pylori infection, dyspepsia, Zollinger-Ellison syndrome, nausea, esophagitis, and asthma, comprises tegoprazan, and excipient. IN202321055693-A[P]. 2023.
条目包含的文件
条目无相关文件。
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。